Analytical Method Validation and Transfer According to the New FDA Guidance Training

Date : 2nd February 2021 to 2nd February 2021

Place : United States, Clyde

Website :https://worldcomplianceseminars.com/

Contact Person:WCs Conference

Description:

This course provides guidance on how to perform QC analytical test method validations and transfers. One of the most critical factors in developing and marketing pharmaceutical drug substances and drug products is ensuring that the analytical methods used for analysis can generate valid data upon which business and regulatory decisions can be made. FDA, ICH and USP have each recognized the importance of this relative to the drug development process and have each expanded method validation requirements in recent years. However, with only limited guidance, industry has been left to interpret how to adequately comply with the regulations. This course provides a comprehensive overview of the international regulatory authority requirements and expectations for test method validation of these assays. This course will prepare attendees with the knowledge and tools to plan and execute test method validation packages for the NDA, BLA and MAA market application dossiers, covering in-process, release and stability assays commonly used by QC. Whether involved in method development, method validation, method verification or method transfer, this course will provide a broad understanding and “hands-on” knowledge of the method validation process and the difficulties encountered in validating methods to comply with today’s upgraded FDA CDER requirements. Lectures will include some of the more common mathematical and statistical treatments of validation data. Because of the tremendous effort that can be expended in conducting validation studies, efficiency of experimental design and documentation will be stressed throughout the discussions.

Analytical Method Validation and Transfer According to the New FDA Guidance Training will be held in Clyde,United States on date 2021-02-02

---

Deadline for abstracts/proposals : 2nd February 2021

Keynote Speakers : Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations.

Conference Highlights :Topic 1: Regulatory Requirements/Guidance on Analytical Method Validation • Terminology defined: qualification, validation, revalidation and verification • FDA, EMA, ICH requirements and guidance • Validation lifecycle for analytical methods Topic 2: Analytical Method Pre-Validation – Stage 1 • Analytical Target Profile (ATP) • ICH Q8, Q9 and Q10 adherence - Pre-Validation Requirements • QC instrumentation qualification • Training

Check the event website for more details.